Tech Moves: Syndio hires managing director; Google travel vet returns to Expedia; ex-Adaptive CMO joins Freenome

— Ritu Mohanka, vice president of approach & improvement EMEA at Glint (element of LinkedIn), is now the running director and head of EMEA at Seattle startup Syndio.

Mohanka has prior expertise at Kenexa Inc. (which later on became IBM Smarter Workforce) and was named on the EMpower Major 100 Ethnic Minority Senior Govt list in 2021. She led the range, inclusion, and belonging initiative at Glint to handle discrimination in using the services of practices.

Syndio presents a computer software resolution that employs facts science to endorse equitable workplaces by monitoring pay and other metrics. Syndio raised $50 million in September. The business is now growing to the United kingdom and EMEA market.

“Diversity, equity, and fair spend are intertwined — and unless you tackle root triggers of inequities, you may perhaps not end up better off than at the begin,” Mohanka mentioned in a statement.

— Expedia Team Media Answers hired Rob Torres as senior vice president. He will oversee Expedia’s international advert small business. He expended far more than 15 yrs at Google as the managing director of advertising and marketing and advertising and marketing for the company’s travel division. Torres also formerly worked at Expedia as vice president of strategic accounts.

— Lance Baldo departed from Adaptive Biotechnologies, a Seattle-based biotech firm, and joined San Francisco-based Freenome as its main healthcare officer.

Baldo has much more than 20 years of experience in health care management. Prior to his place as chief professional medical officer at Adaptive, Baldo was the head of US healthcare affairs for Genentech and the common supervisor for Roche Goods New Zealand’s affiliate.

Freenome is a biotechnology firm targeted on detecting early-phase most cancers in an individual’s blood plasma via artificial intelligence. The organization landed $300 million in venture capital in a Collection D spherical.